MetaVia Inc (MTVA)
2.33
-0.16
(-6.43%)
USD |
NASDAQ |
Jan 07, 16:00
2.40
+0.07
(+3.00%)
After-Hours: 16:05
MetaVia Research and Development Expense (Annual): 9.158M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Dermata Therapeutics Inc | 4.070M |
| Cognition Therapeutics Inc | 37.20M |
| ZyVersa Therapeutics Inc | 3.208M |
| Cytokinetics Inc | -- |
| Ocugen Inc | 39.57M |